- Accueil >
- Publications >
- Evaluation at 3Â years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective study
Evaluation at 3Â years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective study
Auteurs
A. Dautruche, L. Belin, P. Cottu, P. Bontemps, C. Lemanski, B. de la Lande, P. Baumann, F. Missohou, C. Lévy, K. Peignaux, A. Reynaud-Bougnoux, F. Denis, A. Gobillion, V. Pernin, Y. Kirova